Jade Biosciences Inc

$16.82
Market Cap 829.50M
ROE -51.3%
Gross Margin 0.0%
Debt/Equity 0.0
Current Ratio 14.3
Revenue QoQ 0.0%
EPS QoQ -1.0%
F-Score 2

About

Aerovate Therapeutics is a biotechnology company that was focused on improving the lives of patients with rare cardiopulmonary disease.

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-5.84
vs median 35.63
P/B
2.55
vs median 2.25
ROE
-0.51
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics